A vaccine for gonorrhoea will be rolled out in England as part of a world-first programme, officials have announced.
The move, hailed as a “landmark moment for sexual health”, will aim to tackle rising levels of the sexually transmitted infection (STI).
Gonorrhoea cases in England topped 85,000 in 2023, the highest since records began in 1918, with warnings over some strains being resistant to antibiotics.
The vaccine is an existing jab, known as 4CMenB, that is used against the meningococcal B disease, a serious bacterial infection that can cause meningitis and sepsis. It is used in the routine childhood programme and given to babies at eight weeks, 16 weeks and one year.
Dr Amanda Doyle, the national director for primary care and community services at NHS England, said: “The launch of a world-first routine vaccination for gonorrhoea is a huge step forward for sexual health and will be crucial in protecting individuals, helping to prevent the spread of infection and reduce the rising rates of antibiotic resistance strains of the bacteria.”
Eligible patients will be identified and contacted in the coming weeks, with the jab offered through local authority-commissioned sexual health services from 1 August.
At the appointment patients will also be offered jabs for mpox, human papillomavirus (HPV), and hepatitis A and B.
Doyle added: “NHS teams across the country are now working hard to plan the rollout and ensure we hit the ground running, while the routine mpox vaccination programme builds on the vital progress the NHS has made in recent months in reaching as many eligible people as possible.”
Source: The Guardian, 21 May 2025
Recommended Comments
Create an account or sign in to comment